Literature DB >> 14998070

Drugs used for euthanasia in Flanders, Belgium.

R H Vander Stichele1, J J R Bilsen, J L Bernheim, F Mortier, L Deliens.   

Abstract

PURPOSE: Our aim was to describe and assess the medicinal products and doses used for euthanasia in a series of cases, identified within an epidemiological death certificate study in Belgium, where euthanasia was until recently legally forbidden and where guidelines for euthanasia are not available.
METHODS: In a random sample of the deaths in 1998 in Belgium, the physicians who signed the death certificates were identified and sent an anonymous mail questionnaire. The questionnaires of the deaths classified as euthanasia cases were reviewed by a multi-disciplinary panel.
RESULTS: A total of 22 among 1925 questionnaires pertained to voluntary euthanasia. In 17 cases, detailed information on the euthanatics (medicinal substances used for euthanasia) used was provided. Opioids were used in 13 cases (in 7 as a single drug). Time between last dose and expiry ranged from 4 to 900 min. The panel judged that only in 4 cases effective euthanatics were used.
CONCLUSIONS: In the end-of-life decision cases perceived by Belgian physicians as euthanasia, pharmacological practices were disparate, although dominated by the use of morphine, in the very late phase of dying, in doses which were unlikely to be lethal. Most physicians clandestinely engaging in euthanasia in Belgium seemed unaware of procedures for guaranteeing a quick, mild and certain death. Information on the pharmacological aspects of euthanasia should be included in the medical curriculum and continuing medical education, at least in countries with a legal framework permitting euthanasia under specified conditions.

Entities:  

Keywords:  Death and Euthanasia; Empirical Approach

Mesh:

Year:  2004        PMID: 14998070     DOI: 10.1002/pds.863

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  5 in total

1.  The use of drugs with a life-shortening effect in end-of-life care in neonates and infants.

Authors:  Veerle Provoost; Filip Cools; Johan Bilsen; José Ramet; Peter Deconinck; Robert Vander Stichele; Anne Vande Velde; Inge Van Herreweghe; Freddy Mortier; Yvan Vandenplas; Luc Deliens
Journal:  Intensive Care Med       Date:  2005-11-15       Impact factor: 17.440

2.  Communication on end-of-life decisions with patients wishing to die at home: the making of a guideline for GPs in Flanders, Belgium.

Authors:  Reginald Deschepper; Robert Vander Stichele; Jan L Bernheim; Els De Keyser; Greta Van Der Kelen; Freddy Mortier; Luc Deliens
Journal:  Br J Gen Pract       Date:  2006-01       Impact factor: 5.386

3.  The role of nurses in physician-assisted deaths in Belgium.

Authors:  Els Inghelbrecht; Johan Bilsen; Freddy Mortier; Luc Deliens
Journal:  CMAJ       Date:  2010-05-17       Impact factor: 8.262

4.  Characteristics of Belgian "life-ending acts without explicit patient request": a large-scale death certificate survey revisited.

Authors:  Kenneth Chambaere; Jan L Bernheim; James Downar; Luc Deliens
Journal:  CMAJ Open       Date:  2014-10-01

5.  Medications and dosages used in medical assistance in dying: a cross-sectional study.

Authors:  Igor Stukalin; Oluwatobi R Olaiya; Viren Naik; Ellen Wiebe; Mike Kekewich; Michaela Kelly; Laura Wilding; Roxanne Halko; Simon Oczkowski
Journal:  CMAJ Open       Date:  2022-01-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.